এস্তোনিয়া - এস্তোনীয় - Ravimiamet

fgup npo microgen mz rf - kaltsiumkloriid - süstelahus - 100mg 1ml 10ml 10tk

এস্তোনিয়া - এস্তোনীয় - Ravimiamet

fgup “armaviri biofabrika” - kaltsiumkloriid - süstelahus - 100mg 1ml 10ml 10tk

এস্তোনিয়া - এস্তোনীয় - Ravimiamet

serumwerk bernburg ag - kaltsiumkloriid - infusioonilahus - 73,5mg 1ml 100ml 20tk

এস্তোনিয়া - এস্তোনীয় - Ravimiamet

b. braun melsungen ag - naatriumkloriid - süstelahus - 200mg 1ml 20ml 20tk

এস্তোনিয়া - এস্তোনীয় - Ravimiamet

dalhimfarm oao - kaltsiumkloriid - süstelahus - 100mg 1ml 10ml 10tk

এস্তোনিয়া - এস্তোনীয় - Ravimiamet

galychpharm - kaltsiumkloriid - süstelahus - 100mg 1ml 10ml 10tk

এস্তোনিয়া - এস্তোনীয় - Ravimiamet

apex formulations pvt. ltd. - kaaliumkloriid - toimeainet prolongeeritult vabastav tablett - 600mg 100tk

এস্তোনিয়া - এস্তোনীয় - Ravimiamet

darnitsa pharmaceutical firm prat - kaltsiumkloriid - süstelahus - 100mg 1ml 10ml 10tk

ইউরোপীয় ইউনিয়ন - এস্তোনীয় - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformiin vesinikkloriid - suhkurtõbi, tüüp 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

ইউরোপীয় ইউনিয়ন - এস্তোনীয় - EMA (European Medicines Agency)

novartis europharm limited  - vildagliptin, metformiin vesinikkloriid - suhkurtõbi, tüüp 2 - diabeetis kasutatavad ravimid - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.